Want to join the conversation?
Keith Weiss of Morgan Stanley asks about the weakness seen at the end of 2Q17. $CRM said it saw some weakness and some softness in parts of its business in the US. The company conducted an operational review and has made some adjustments. $CRM feels positive about 2H17 as it believes the pipeline is strong.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?